MoleculeAI's Quest: Revolutionizing Drug Discovery with Artificial Intelligence

In a rapidly evolving world where scientific breakthroughs are essential for the betterment of healthcare, MoleculeAI stands at the forefront, pioneering t...

September 11, 2023 | Monday | Interaction
Bayer President, Sebastian Guth, Highlights Alarming Link: Rising Fear, Lack of Education, and Distrust Hinder Access to Vital Preventative Care

One in Four American Adults Would Rather Not Know They Have Cancer   A new study from The Harris Poll, commissioned by Bayer, suggests fear factors ...

August 22, 2023 | Tuesday | Analysis
Study Finds Benefits of Telephone Cognitive Behavioural Therapy for Bariatric Surgery Patients

New research looking at the mental health and eating behaviours of patients 1-year after bariatric surgery has found that a short, 7-session telephone cogn...

August 04, 2023 | Friday | News
Agilent’s 2022 ESG Report Shows Progress Helping Customers Reach Their Sustainability Goals

“Agilent is committed to our customers’ success at every stage of their journey to bring great science to life,” said Agilent President a...

August 01, 2023 | Tuesday | Reports
Promising At-Home Testing for Sexually Transmitted Infections Revealed in New Research

Self-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs), according to research pre...

July 31, 2023 | Monday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Radioligand Binding Assays: From Opiate Receptors to Drug Discovery Mainstay

Using radioactive ligand binding methods, Dr. Snyder’s team found that the receptors were highly concentrated in areas of the brain involved in the s...

July 04, 2023 | Tuesday | Analysis
TLX250-CDx Shows Potential Utility in ccRCC Staging: New ZIRCON Phase III Data Presented in Australia.

New data demonstrates the ability of TLX250-CDx to detect extrarenal lesions, supporting potential clinical utility in the metastatic or recurrent setting,...

June 27, 2023 | Tuesday | News
Medtronic's MiniMed™ 780G System Shows Promising Data on Meal Dosing and Time in Range

These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting gly...

June 26, 2023 | Monday | News
Cytiva launches 2023 Biopharma Resilience Index

Biopharma’s own leaders express a declining sense of industry resilience in the latest wide-reaching survey from Cytiva. The Global Biopharma Resilie...

June 22, 2023 | Thursday | Reports
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks

23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report as part of the 23andMe+ sub...

June 22, 2023 | Thursday | Reports
Deloitte Launches 'Illustrate Change' Medical Illustration Library

Deloitte is proud to announce the launch of "Illustrate Change," a project that seeks to build momentum around representation in medical illustrations and ...

June 21, 2023 | Wednesday | News
Gradient Health Raises $2.75M to Build World's Largest Medical Imaging Library

Joining ReMY on the round were new investors Boro Capital, Supernode Ventures, MedMountain Ventures, The Triangle Tweener Fund, David Golan, and Silic...

June 20, 2023 | Tuesday | News
Promising Results in Early-Stage Study of Hodgkin Lymphoma with Tessa Therapeutics' 'Off-the-Shelf' CAR-T Therapy

Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...

June 16, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in